Services
Our Services
We track 500+ generics, 100+ biosimilars, and 10+ peptides, monitoring launches, regulatory strategies, clinical progress, market access, and partnerships to deliver a comprehensive view of the evolving competitive landscape
01.
Therapeutic Expertise
Deep experience across oncology, immunology, rare diseases, CNS, cardiovascular, metabolic, respiratory, generics and biosimilars
02.
Lifecycle Strategy
End-to-end pipeline evaluation, BD&L support, pricing, market access, loss of exclusivity navigation
03.
Regulatory Intelligence
Insights on market dynamics, global regulations (FDA, EMA), launch timelines, access pathways, pricing, and promotional strategies
04.
Standard Delivery
Project-based and flexible FTE models, onshore/offshore, ensuring agile, priority-aligned support
Research Framework
Our CI Engagement Framework ensures a structured approach, from defining scope to delivering actionable insights and strategic recommendations
Primary Research
Targeted outreach across intelligence network
Interim Updates
Preliminary insights consolidation and strategic course adjustment
Secondary Research
Deep-dive analysis using validated global sources
Final Deliverable
Comprehensive reporting with strategic recommendations
Scope Definition
Co-define intelligence objectives and research parameters